CORBF Stock Chart & Stats
$0.95
>-$0.01(-0.11%)
At close: 4:00 PM EDT
$0.95
>-$0.01(-0.11%)
Day’s Range― - ―
52-Week Range$0.20 - $1.45
Previous CloseN/A
Volume458.00
Average Volume (3M)1.46K
Market Cap
$127.35M
Enterprise Value-$5.80B
Total Cash (Recent Filing)$1.05B
Total Debt (Recent Filing)$23.00K
Price to Earnings (P/E)1.5
Beta-0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.74
Shares Outstanding133,914,720
10 Day Avg. Volume304
30 Day Avg. Volume1,457
Financial Highlights & Ratios
PEG Ratio-4.13
Price to Book (P/B)0.61
Price to Sales (P/S)2.39
P/FCF Ratio5.00
Enterprise Value/Market Cap-45.55
Enterprise Value/Revenue-9.76
Enterprise Value/Gross Profit-11.36
Enterprise Value/Ebitda-19.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Global Cord Blood News
CORBF FAQ
What was Global Cord Blood’s price range in the past 12 months?
Global Cord Blood lowest stock price was $0.20 and its highest was $1.45 in the past 12 months.
What is Global Cord Blood’s market cap?
Global Cord Blood’s market cap is $127.35M.
When is Global Cord Blood’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Global Cord Blood’s earnings last quarter?
Global Cord Blood released its earnings results on Jul 05, 2022. The company reported $0.136 earnings per share for the quarter.
Is Global Cord Blood overvalued?
According to Wall Street analysts Global Cord Blood’s price is currently Overvalued.
Does Global Cord Blood pay dividends?
Global Cord Blood pays a Notavailable dividend of $0.08 which represents an annual dividend yield of N/A. See more information on Global Cord Blood dividends here
What is Global Cord Blood’s EPS estimate?
Global Cord Blood’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Cord Blood have?
Global Cord Blood has 133,914,720 shares outstanding.
What happened to Global Cord Blood’s price movement after its last earnings report?
Global Cord Blood reported an EPS of $0.136 in its last earnings report. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Global Cord Blood?
Currently, no hedge funds are holding shares in CORBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Cord Blood
Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Technical Analysis
Myriad Genetics
―
Natera
―
Prenetics Group
―
Sera Prognostics
―
BillionToOne, Inc. Class A
―